Press release
The Latest Innovations in HPAPI Manufacturing Technologies
SMi’s inaugural Highly Potent Active Pharmaceutical Ingredients USA Conference, will focus on the latest innovative manufacturing technologies with a special spotlight presentation on effective and safe containment solutions for biologics based HPAPIs, along with cleaning and cross contamination requirements.Keith Jensen, Owner and Consultant at Keith Jensen Consulting, previously at Novartis-MIT Center for Continuous Manufacturing, discusses alternative HPAPI manufacturing technologies to reduce powder exposure and improve safety enabling continuous manufacturing. Other points to be discussed include:
- Alternative drug manufacture through nanocrystal formulations, thin films and hot-melt extrusion/injection molding that reduces HPAPI powder exposure and improve safety
- Step-by-step processes along with the equipment needed to achieve alternative HPAPI manufacturing techniques
Richard Denk, Head of Sales Containment from SKAN focuses on:
- Regulatory requirements for highly potent biologics-based Pharmaceuticals
- Requirements for aseptic manufacturing and Containment
- Cleaning and Cross Contamination Requirements
Also, up for discussion will be emerging bispecific HPAPI therapy, from development to manufacturing and multipurpose facilities, along with what level of super high-level band 5 containment is required.
For those interested, a special discounted rate is available for conference tickets booked before August 30th. Register online at www.hpapi-usa.com/PR4
Sponsored by BSP Pharmaceuticals | LONZA | Minakem | SafeBridge Consultants
Highly Potent Active Pharmaceutical Ingredients USA
Conference: October 21st – 22nd
Workshops: October 23rd
Venue: Sheraton Boston Hotel, USA
For delegate enquiries, please contact Fateja Begum on +44 (0)20 7827 6184 or fbegum@smi-online.co.uk
For sponsorship, exhibition and branding enquiries, please contact Alia Malick on +44 (0)20 7827 6168 or amalick@smi-online.co.uk
For media enquiries contact Neill Howard on Tel: +44 (0)20 7827 6164 or nhoward@smi-online.co.uk
India House, 45 Curlew Street
Event organizers
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Latest Innovations in HPAPI Manufacturing Technologies here
News-ID: 1799802 • Views: …
More Releases from SMi Group Ltd
Co-chairs invitation to attend the Pharmaceutical Cleanrooms Conference in Londo …
SAE Media Group reports: Conference co-chairs invite you to attend the 2nd Annual Next Generation Pharmaceutical Cleanrooms this October 2022.
The conference will be co-chaired by Conor Murray, Chairman, Irish Cleanroom Society and Connor McMorrow, Aseptic Lead Cell Therapy, Takeda, in which they have released an invitation letter for all interested parties.
Excerpt of the Co-Chair invitation letter:
'As joint chairs of the 2nd Annual Next Generation Pharmaceutical Cleanrooms Conference, it is our…
Exclusive Speaker Interview with Karen Capper, AstraZeneca ahead of the Pharmace …
SMi Group reports: exclusive speaker interview with microbiology expert Karen Capper, AstraZeneca about the developments in the microbiology field.
Now in its 10th Annual year, the Pharmaceutical Microbiology UK conference is one not to be missed. Taking place on 17th and 18th January 2022 as a virtual conference with online access only.
The conference will bring together industry experts to discuss and analyse the latest advancements and challenges within pharmaceutical microbiology.
Interested…
SMi’s 3D Cell Culture conference 2022 – Speakers announced
SMi Reports: Agenda and speaker overview of the upcoming 5th Annual 3D Cell Culture Conference.
SMi Group is delighted to announce the return of the successful 3D Cell Culture Conference for its 5th year, taking place on 9th and 10th February 2022 in London, UK. Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in…
Maritime Safety Briefings to Look Forward to at Defence Safety 2020
Defence Safety 2020 will provide a comprehensive overview of safety within the military, aiming to review the safe delivery of defence capabilities, and the parts that operational users, equipment, and service delivery organisations, as well as research and development play.
Once again supported by the UK MoD Defence Safety Authority, the event will feature a diverse, international speaker line-up of military and industry experts, who will explore the latest updates on…
More Releases for HPAPI
High Potency APIs/ HPAPI Market Analysis and Outlook Report (2025-2034)
The high potency APIs/ HPAPI market is expected to grow at 8.14% CAGR from 2021 to 2029. It is expected to reach above USD 39.8 Billion by 2029 from USD 19.67 Billion in 2020.
On March 31, 2025, Exactitude Consultancy., Ltd. released a research report offers a comprehensive examination of the various processes and materials used in the production of High Potency APIs/ HPAPI market goods. The market study excludes key…
Cytotoxic Drugs and HPAPI Manufacturing Market
Cytotoxic Drugs and HPAPI Manufacturing Market worth $27.1 Bn by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Cytotoxic Drugs and HPAPI Manufacturing Market- (Type of Product (HPAPI and highly potent finished dosage form), Company Size (Small, Mid-sized, Large, Very Large), Scale of Operation (Preclinical, clinical, commercial), Type of Molecule (Small molecules, biologics), Type of Highly Potent…
HPAPI Market Player Profiling, Forecast till 2028
According to Ameco Research 'HPAPI Market report, the analysts took this into account when estimating the HPAPI Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the HPAPI Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes HPAPI Market trends, segmentation, key companies, SWOT, PORTER and…
HPAPI Market Size Forecast till 2028
According to Ameco Research 'HPAPI Market report, the analysts took this into account when estimating the HPAPI Market size and CAGR for the respective industry. The report's author has thoroughly examined the market and concluded that the HPAPI Market 's growth will level off in the coming years. In addition to that, the prominent qualitative information added in the report includes HPAPI Market trends, segmentation, key companies, SWOT, PORTER and…
High Potent Active Pharmaceutical Ingredient (HPAPI) Market Size, Share | Trend …
Ameco Research Analyst imply that the global market for high potent active pharmaceutical ingredient (HPAPI) will raise at a CAGR of more than 8% throughout the forecast period, with market size of US$ 21.5 Bn in 2020.
The intended function of an API, according to the FDA, is to provide pharmacological activity or another direct effect in the diagnosis, mitigation, treatment, cure, or prevention of disease, or to modify the structure…
High Performance Active Pharmaceutical Ingredients (HPAPI) Market 2022 | Detaile …
This report provides an informative view about the competitive aspect of the global market. It includes detailed picture of the exhibition of a portion of the essential global players working in the High Performance Active Pharmaceutical Ingredients (HPAPI) market. The research study also provides historical record with profits predictions and forecasts from 2022 to 2028. Also, the business manufacturing of the notable manufacturers is also emphasized with technical data in…
